MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases

MRgFUS is a safe, noninvasive method to deliver spatially targeted monoclonal antibody across the BBB in patients with brain tumors.

Read the full article here

Related Articles